相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2023)
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
Hisashi Saji et al.
LANCET (2022)
Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer
Aritoshi Hattori et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)
Development and Validation of Machine Learning-based Model for the Prediction of Malignancy in Multiple Pulmonary Nodules: Analysis from Multicentric Cohorts
Kezhong Chen et al.
CLINICAL CANCER RESEARCH (2021)
Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers
Chunhong Hu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Surgical Prognosis of Synchronous Multiple Primary Lung Cancer: Systematic Review and Meta-Analysis
Yuntao Nie et al.
CLINICAL LUNG CANCER (2021)
The impact of postoperative EGFR-TKIs treatment on residual GGO lesions after resection for lung cancer
Bo Cheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
A Novel Algorithm to Differentiate Between Multiple Primary Lung Cancers and Intrapulmonary Metastasis in Multiple Lung Cancers With Multiple Pulmonary Sites of Involvement
Young Joo Suh et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Profiles of Lung Adenocarcinoma With Multiple Ground-Glass Opacities and the Fate of Residual Lesions
Yoshihisa Shimada et al.
ANNALS OF THORACIC SURGERY (2020)
Radiofrequency ablation of synchronous multiple primary lung cancer assisted by a magnetic navigation system: a case report
Jiajun Teng et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
CCND1Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors
Yu Chen et al.
FRONTIERS IN IMMUNOLOGY (2020)
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma
Siwei Wang et al.
NATURE COMMUNICATIONS (2020)
Multiple primary lung cancer: a rising challenge
Chen Chen et al.
JOURNAL OF THORACIC DISEASE (2019)
Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers
John Nikitas et al.
CLINICAL LUNG CANCER (2019)
Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing
Yaxiong Zhang et al.
MOLECULAR CANCER (2019)
m6A mRNA methylation sustains Treg suppressive functions
Jiyu Tong et al.
CELL RESEARCH (2018)
ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection
Yi-Long Wu et al.
CLINICAL LUNG CANCER (2018)
Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin section computed tomography
Aritoshi Hattori et al.
LUNG CANCER (2017)
Survival rate and prognostic factors of surgically resected clinically synchronous multiple primary non-small cell lung cancer and further differentiation from intrapulmonary metastasis
Fei Xiao et al.
JOURNAL OF THORACIC DISEASE (2017)
The Eighth Edition Lung Cancer Stage Classification
Frank C. Detterbeck et al.
CHEST (2017)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Genomic heterogeneity of multiple synchronous lung cancer
Yu Liu et al.
NATURE COMMUNICATIONS (2016)
Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
Zhirong Zhang et al.
SCIENTIFIC REPORTS (2016)
Special Treatment Issues in Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Benjamin D. Kozower et al.
CHEST (2013)
Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201
Hisao Asamura et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)
A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)
Kenji Suzuki et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Multiple Primary Cancers or Multiple Metastases, That Is the Question
Hisao Asamura
JOURNAL OF THORACIC ONCOLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Special treatment issues in lung. cancer - ACCP evidence-based clinical practice guidelines (2nd edition)
K. Robert Shen et al.
CHEST (2007)
分享论文
